Heart & lung : the journal of critical care · 2026
Prognostic significance of isolated left bundle branch block in patients presenting with chest pain without prior cardiometabolic disease.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Abazie Nadine, Obialor Michael, Sob Joyce, Agha Muhammad Asim, Azhar Muhammad Junaid, Tazuh Ella, Saqer Sammy, Michael Miriam
Аннотация
BACKGROUND: Left bundle branch block (LBBB) is a cardiac abnormality frequently associated with structural heart disease and adverse cardiovascular outcomes. However, its prognostic significance in patients without prior cardiometabolic disease remains unclear.
OBJECTIVE: To evaluate cardiovascular outcomes in patients presenting with chest pain with versus without LBBB in the absence of prior cardiometabolic or structural heart disease.
METHODS: We conducted a retrospective cohort study using TriNetX. Adults presenting with chest pain were divided into two cohorts: patients with LBBB and patients without LBBB. Patients with prior cardiometabolic or structural heart disease were excluded. Propensity score matching was performed, yielding 12,035 patients in each cohort. Outcomes included myocardial infarction, heart failure, and incident heart disease.
RESULTS: After matching, patients with LBBB had higher rates of myocardial infarction compared with patients without LBBB (3.8%vs 1.4%, p<0.001). Heart failure was also more common in the LBBB cohort (13.2%vs 4.5%, p<0.001). Incident heart disease occurred in 3.4% of patients with LBBB compared with 0.9% of patients without LBBB (p<0.001). Kaplan-Meier analysis demonstrated significantly worse event-free survival for myocardial infarction, heart failure, and heart disease among patients with LBBB.
CONCLUSION: Among patients presenting with chest pain without prior cardiometabolic or structural heart disease, LBBB was associated with increased risks of MI, HF, and heart disease. These findings suggest an association between LBBB and adverse cardiovascular outcomes in this population.
OBJECTIVE: To evaluate cardiovascular outcomes in patients presenting with chest pain with versus without LBBB in the absence of prior cardiometabolic or structural heart disease.
METHODS: We conducted a retrospective cohort study using TriNetX. Adults presenting with chest pain were divided into two cohorts: patients with LBBB and patients without LBBB. Patients with prior cardiometabolic or structural heart disease were excluded. Propensity score matching was performed, yielding 12,035 patients in each cohort. Outcomes included myocardial infarction, heart failure, and incident heart disease.
RESULTS: After matching, patients with LBBB had higher rates of myocardial infarction compared with patients without LBBB (3.8%vs 1.4%, p<0.001). Heart failure was also more common in the LBBB cohort (13.2%vs 4.5%, p<0.001). Incident heart disease occurred in 3.4% of patients with LBBB compared with 0.9% of patients without LBBB (p<0.001). Kaplan-Meier analysis demonstrated significantly worse event-free survival for myocardial infarction, heart failure, and heart disease among patients with LBBB.
CONCLUSION: Among patients presenting with chest pain without prior cardiometabolic or structural heart disease, LBBB was associated with increased risks of MI, HF, and heart disease. These findings suggest an association between LBBB and adverse cardiovascular outcomes in this population.